On the 29th, the EU-European Union issued a permit to use the new coronavirus vaccine developed by British pharmaceutical giant AstraZeneca and others.
This is the third EU approval of the new corona vaccine.
On the 29th, the EU's European Pharmaceutical Agency reviewed vaccines developed by AstraZeneca and the University of Oxford and recommended that a marketing license be issued on condition that it be used by people over the age of 18. The association immediately issued formal permission.
The EU has issued a new coronavirus vaccine, which is the third case after Pfizer, a major US pharmaceutical company, and Moderna, a pharmaceutical company in the United States.
In a statement, European Commission Chairman Von der Leyen emphasized the significance of "vaccine security is a top priority. This will add 400 million doses of vaccine."
Regarding the AstraZeneca vaccine, a committee of German experts has announced a policy to recommend vaccinations between the ages of 18 and 64, citing lack of efficacy data for vaccinations over the age of 65. However, the European Pharmaceutical Agency acknowledged that the data for people aged 55 and over are still inadequate, but that there is no problem with vaccination for the elderly.